Table 2.
Simulation cohort baseline characteristics
| Characteristic | Value | Reference |
| Age (years) | 64.2 | [20] |
| Duration of diabetes (years) | 4 | [21] |
| Percentage male (%) | 55.26 | [20] |
| Clinical parameters | ||
| HbA1c (%) | 8.16 | [20] |
| SBP (mmHg) | 141 | [30] |
| Total cholesterol (mg/dl) | 214.5 | [30] |
| HDL-cholesterol (mg/dl) | 42.9 | [30] |
| LDL-cholesterol (mg/dl) | 128.7 | [30] |
| Triglycerides (mg/dl) | 204.7 | [30] |
| BMI (kg/m2) | 30.1 | [20] |
| Ethnicity | ||
| Proportion White (%) | 82 | Assumed* |
| Proportion Black (%) | 9 | Assumed* |
| Proportion Asian (%) | 9 | Assumed* |
| Comorbidities at baseline | ||
| Myocardial infarction (%) | 8.2 | [31] |
| Peripheral vascular disease (%) | 4.5 | [30] |
| Stroke (%) | 6.6 | [30] |
| Congestive heart failure (%) | 22.8 | [30] |
| Microalbuminuria (%) | 0.7 | [31] |
| End-stage renal disease (%) | 1 | [31] |
| Background diabetic retinopathy (%) | 17.7 | [31] |
| Neuropathy (%) | 6.5 | [31] |
HbA1c -- glycosylated haemoglobin; SBP -- systolic blood pressure; HDL -- high-density lipoprotein; LDL -- low-density lipoprotein; BMI -- body mass index; * no data found and so assumed